Publication: Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis
No Thumbnail Available
Date
2022-09-26
Authors
Şenol H.
Özgün-Acar Ö.
Dağ A.
Eken A.
Acar B.
Aktaş Pepe N.
Güner H.
Aykut Z. G.
Çevik Kaplan S.
Ayaz Güner Ş.
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Description
Keywords
Yaşam Bilimleri, Moleküler Biyoloji ve Genetik, Temel Bilimler, Life Sciences, Molecular Biology and Genetics, Natural Sciences, Temel Bilimler (SCI), Yaşam Bilimleri (LIFE), Doğa Bilimleri Genel, ÇOK DİSİPLİNLİ BİLİMLER, Natural Sciences (SCI), Life Sciences (LIFE), NATURAL SCIENCES, GENERAL, MOLECULAR BIOLOGY & GENETICS, MULTIDISCIPLINARY SCIENCES, Moleküler Biyoloji, Multidisipliner, Molecular Biology, Multidisciplinary
Citation
Şenol H., Özgün-Acar Ö., Dağ A., Eken A., Acar B., Aktaş Pepe N., Güner H., Aykut Z. G., Çevik Kaplan S., Ayaz Güner Ş., et al., \"Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis\", I. International Advances in Molecular Biology Congress, İstanbul, Türkiye, 19 - 22 Eylül 2022, ss.55-56